Tania D. Dimitrova


tania.dimitrova.wg11@wharton.upenn.edu Mount Holyoke College, South Hadley, MA B.A., Cum Laude, Economics, Mathematics, 2003


Rafael C. Donnay


rafael.donnay.wg11@wharton.upenn.edu Columbia University, New York, NY B.S., Mechanical Engineering, 2000 Stanford University, Stanford, CA M.S., Mechanical Engineering, 2002


Nathan Etessami nathan.etessami.wg11@wharton.upenn.edu


Princeton University, Princeton, NJ B.S.E., Magna Cum Laude, Phi Beta Kappa, Chemical Engineering, 2006


An opportunity to leverage my health care knowledge and background in finance.


Becton, Dickinson and Company, Franklin Lakes, NJ


Global Marketing Summer Associate, BD Diagnostics – Preanalytical Systems, Summer 2010


Developed a framework to quantify the environmental impact of a recent- ly launched product, which included detailed cost and product life cycle analyses. Designed an external communications plan to publicize the results of the project and presented recommendations to the CEO.


Credit Suisse Private Banking – Switzerland, New York, NY Vice President, Senior US Health Care Analyst, 2006-2009


Analyzed and determined investment recommendations for 40 large and mid-cap US health care companies. Coordinated team of three interna- tional health care analysts, and managed flow of health care-related investment ideas and products within Equity Research Department. Conducted quarterly presentations to Credit Suisse Asset Management. Wrote investment idea and research reports which identify long-term glob- al health care themes and developed long/short trades.


Credit Suisse Investment Banking, New York, NY


Equity Research Associate, US Pharmaceuticals, 2003-2006


Performed company and sector analy- sis in support of Institutional Investor ranked senior analyst. Built company models and wrote company specific and industry wide reports. Com mun i - cated investment ideas to internal sales force, sector traders and clients.


An opportunity within an entrepreneur- ial team in the medical device industry.


L.E.K. Consulting, San Francisco, CA Summer Consultant, Summer 2010 Managed team of associates in performing a valuation using a lifecy- cle analysis of comparables. Evaluated trends for revenue and cost drivers in the cable television industry.


Abbott Laboratories, Alameda, CA Strategic Marketing Associate, Summer 2010


Evaluated the business case for adding a service-based revenue model to the existing diabetes product line. Persuaded senior management to move forward with a pilot study to evaluate the financial and therapeutic benefits of a service-based treatment intervention.


St. Jude Medical, Sunnyvale, CA Clinical & Systems Engineer, 2002-2007 Program Manager, Strategic Marketing, 2007-2009


Led two-year crossfunctional Strategic Leadership Team of 13 resulting in fulfilling customers’ unmet needs. Coordinated global customer market research and analyzed industry landscape. Performed GAP analysis and competitive benchmarking that identified cause of low market penetration due to product defect. Persuaded senior management to prioritize this project and allocate additional necessary resources. Presented monthly updates to Division President. Developed goals and strategy to design both incremental and breakthrough technological solutions to address immediate and long-term needs of customers.


An opportunity in strategy, portfolio management, or market planning at a biopharmaceutical company.


Genentech, South San Francisco, CA MBA Intern, Pipeline and Portfolio Planning, Summer 2010


Assessed status of more than 150 Roche R&D projects with respect to development in China, identifying potential opportunities and chal- lenges, and recommending portfolio prioritization strategies to Asia-Pacific regional leaders.


The Boston Consulting Group, New York, NY


Consultant, 2008-2009 Associate, 2006-2008 Worked with a variety of clients primarily in the health care industry. Project experience includes creating a portfolio segmentation framework and defining the segment strategy for a vaccines company, redesigning structure, size, and role of hospital sales division for global biopharma company, and valuing four drug part- nership opportunities for the business development group of global biophar- ma company.


13


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40